asparagine has been researched along with Hypophosphatasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shawafi, HA; Amizuka, N; Makita, S; Oda, K; Sohda, M; Sultana, S; Takagi, R | 1 |
| Cahill, R; Gottesman, GS; Grubb, JH; Gutierrez, MA; Kanai, R; Kobayashi, H; Lopez, PL; Miyamoto, K; Nishioka, T; Noguchi, A; Sly, WS; Tomatsu, S; Trandafirescu, GG; Yamaguchi, S | 1 |
| Amizuka, N; Ito, M; Oda, K; Ozawa, H | 1 |
3 other study(ies) available for asparagine and Hypophosphatasia
| Article | Year |
|---|---|
An asparagine at position 417 of tissue-nonspecific alkaline phosphatase is essential for its structure and function as revealed by analysis of the N417S mutation associated with severe hypophosphatasia.
Topics: Alkaline Phosphatase; Amino Acid Substitution; Animals; Asparagine; Chlorocebus aethiops; CHO Cells; Codon; COS Cells; Cricetulus; Gene Expression; Humans; Hypophosphatasia; Mutation | 2013 |
Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide.
Topics: Alkaline Phosphatase; Animals; Asparagine; Bone Marrow Cells; Calcification, Physiologic; Cells, Cultured; Cricetinae; Cricetulus; Durapatite; Humans; Hypophosphatasia; Infant; Liver; Mice; Oligopeptides; Tissue Distribution | 2006 |
Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153-->Asp substitution, a cause of perinatal hypophosphatasia.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Asparagine; Aspartic Acid; Biological Transport; Biotinylation; Brefeldin A; Cell Membrane; Centrifugation, Density Gradient; COS Cells; Dimerization; Golgi Apparatus; Humans; Hypophosphatasia; Microscopy, Fluorescence; Mutation; Mutation, Missense; Plasmids; Precipitin Tests; Protein Folding; Protein Synthesis Inhibitors; Time Factors; Transfection; Type C Phospholipases | 2002 |